Impact of Misclassification and Imperfect Serological Tests in Association Analyses of ME/CFS Applied to COVID-19 Data
The diagnosis of ME/CFS is problematic due to the absence of a disease specific biomarker.
As such, it is conducted under uncertainty using symptom-based criteria and the exclusion of …
As such, it is conducted under uncertainty using symptom-based criteria and the exclusion of …
Impact of Misclassification and Imperfect Serological Tests in Association Analyses of ME/CFS Applied to COVID-19 Data
J Malato, L Graça, N Sepúlveda - Recent Developments in Statistics and Data … - Springer
The diagnosis of ME/CFS is problematic due to the absence of a disease specific biomarker.
As such, it is conducted under uncertainty using symptombased criteria and the exclusion of …
As such, it is conducted under uncertainty using symptombased criteria and the exclusion of …
Impact of Misclassification and Imperfect Serological Tests in Association Analyses of ME/CFS Applied to COVID-19 Data
J Malato, L Graça, N Sepúlveda - Recent Developments in …, 2022 - books.google.com
The diagnosis of ME/CFS is problematic due to the absence of a disease specific biomarker.
As such, it is conducted under uncertainty using symptombased criteria and the exclusion of …
As such, it is conducted under uncertainty using symptombased criteria and the exclusion of …